Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 47, 2023 - Issue 3
67
Views
1
CrossRef citations to date
0
Altmetric
Rapid Communication

A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [HBB: c.206T > C β 68(E12) Leu-Pro]: A First Report in the Chinese Population

, , , , , , & ORCID Icon show all
Pages 130-134 | Received 15 Sep 2022, Accepted 17 Jun 2023, Published online: 28 Jul 2023

References

  • Huang SW, Liu XM, Li GF, et al. Spectrum of β-thalassemia mutations in Guizhou Province, PR China, including first observation of codon 121 (GAA > TAA) in Chinese population. Clin Biochem. 2013;46(18):1865–1868. doi: 10.1016/j.clinbiochem.2013.09.014.
  • Huang SW, Xu Y, Liu XM, et al. The prevalence and spectrum of α-thalassemia in Guizhou Province of South China. Hemoglobin. 2015;39(4):260–263. doi: 10.3109/03630269.2015.1041037.
  • Brennan SO, Wells RM, Smith H, et al. Hemoglobin Brisbane: beta68 Leu replaced by His. A new high oxygen affinity variant. Hemoglobin. 1981;5(4):325–335. doi: 10.3109/03630268108991807.
  • Ferreira C, Hoyer JD, Miranda A, et al. Hemoglobin Loves Park [beta68 (E12) Leu–>Phe]: report of five cases including one originating from a de novo mutation. Am J Hematol. 2006;81(4):256–261. doi: 10.1002/ajh.20548.
  • Ohba Y, Miyaji T, Matsuoka M, et al. Hemoglobin Mizuho or beta 68 (E 12) leucine leads to proline, a new unstable variant associated with severe hemolytic anemia. Hemoglobin. 1977;1(5):467–477. doi: 10.3109/03630267709027864.
  • Labotka RJ, Vida LN, Honig GR. Hb Mizuho [beta 68(E12)Leu––Pro]. Second occurrence identified in a Caucasian child with hemolytic anemia and dense erythrocyte inclusions. Hemoglobin. 1990;14(2):129–136. doi: 10.3109/03630269009046954.
  • Keeling MM, Bertolone SJ, Baysal E, et al. Hb Mizuho or alpha 2 beta (2)68(E12)Leu––Pro in a Caucasian boy with high levels of Hb F; identification by sequencing of amplified DNA. Hemoglobin. 1991;15(6):477–485. doi: 10.3109/03630269109027895.
  • Brock MA, Bleiweis MS, Reid J, et al. Recurrent nonbacterial thrombotic endocarditis: a novel therapeutic approach. J Cardiol Cases. 2018;17(5):175–177. doi: 10.1016/j.jccase.2018.01.005.
  • Sarker TT, Delvadia B, Li S, et al. Mizuho hemoglobinopathy, presenting with severe hemolytic anemia and multisystem organ failure secondary to exertion. Transfusion. 2021;61(7):1996–1997. doi: 10.1111/trf.16522.
  • Harthoorn-Lasthuizen EJ, Nabben FA, Kazanetz EG, et al. HB Mizuho or alpha 2 beta 2 68(E12)Leu–>Pro in a young Dutch boy. Hemoglobin. 1995;19(3-4):203–206. doi: 10.3109/03630269509036941.
  • Stolmeijer TM, van der Berg AP, Koeze J, et al. Interplay of co-inherited diseases can turn benign syndromes in a deadly combination: haemoglobinopathy and bilirubin transport disorder. Neth J Med. 2015;73(5):247–252.
  • Perera PS, Silva I, Hapugoda M, et al. Rare hemoglobin variants: Hb G-Szuhu (HBB: c.243C > G), Hb G-Coushatta (HBB: c.68A > C) and Hb Mizuho (HBB: c.206T > C) in Sri Lankan families. Hemoglobin. 2015;39(1):62–65. doi: 10.3109/03630269.2014.992530.
  • Njue L, Medri C, Keller P, et al. The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review. Ann Hematol. 2021;100(7):1677–1683. doi: 10.1007/s00277-021-04458-3.
  • Yadav DD, Jamwal M, Singh N, et al. Hb Mizuho (HBB: c.206T > C): pitfalls of screening tests in an unstable hemoglobin variant diagnosed after targeted next-generation sequencing. Hemoglobin. 2021;45(5):338–340. doi: 10.1080/03630269.2022.2034642.
  • Iolascon A, Andolfo I, Barcellini W, et al. Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica. 2017;102(8):1304–1313. doi: 10.3324/haematol.2016.161166.
  • Rodeghiero F, Ruggeri M. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol. 2012;158(1):16–29. doi: 10.1111/j.1365-2141.2012.09146.x.
  • Ataga KI. Hypercoagulability and thrombotic complications in hemolytic anemias. Haematologica. 2009;94(11):1481–1484. doi: 10.3324/haematol.2009.013672.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.